The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,294.00
Bid: 1,294.00
Ask: 1,297.00
Change: 15.00 (1.17%)
Spread: 3.00 (0.232%)
Open: 1,297.00
High: 1,314.00
Low: 1,284.00
Prev. Close: 1,279.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE 100 Charges Ahead Even As Rolls-Royce Drags

Tue, 26th Jan 2021 12:12

(Alliance News) - London stocks on Tuesday bounced back from a soft start to the week as markets look ahead of a busy week for US corporate earnings and hang on to Washington stimulus hopes.

Rolls-Royce pared early losses in the FTSE 100 while Indivior rallied to the top of the mid-cap FTSE 250.

The FTSE 100 index was up 45.31 points, or 0.7%, at 6,684.16 on Tuesday. The FTSE 250 index was up 138.21 points, or 0.4%, at 20,488.62. The AIM All-Share index was down 0.3% at 1,195.57.

The Cboe UK 100 index was up 0.8% at 664.52. The Cboe 250 was up 0.7% at 17,799.97, and the Cboe Small Companies down 0.4% at 12,176.09.

"Investors seem willing to look past [Friday's] poor PMI data, either reasoning that things will get better from here as vaccination programmes ramp up, or more likely they have nowhere else to go given the lack of income available outside equities," said Chris Beauchamp, chief market analyst at IG.

"The rally since November has slowed noticeably, but it has yet to move to the downside, and instead most indices are content to tread water, with a decent earnings season in the US and expectations of fiscal stimulus providing a reason to hang around the party until the situation improves."

US corporate earnings continue on Tuesday, with Microsoft and American Express among some of the companies reporting. Later in the week come results from the likes of Apple, Boeing, Facebook, Tesla and Visa.

Ahead of the reports, Wall Street was pointed to a mixed open. The Dow Jones is called up 0.1%, the S&P 500 down 0.1% and the Nasdaq Composite down 0.2%.

In mainland Europe, the CAC 40 in Paris was up 1.0% while the DAX 30 in Frankfurt surged 1.4% on Tuesday. The euro was higher, at USD1.2164 versus USD1.2125 late Monday.

Sterling firmed to USD1.3670 at midday from USD1.3655 at the London equities close on Monday.

The unemployment rate for the three months to November came in at 5.0%, up from 4.9% in the three months to October but beating consensus, according to FXStreet, of a steeper rise to 5.1%.

Early estimates for December indicate that the number of payrolled employees fell by 2.7% compared with a year ago, marking a fall of 793,000 employees, the ONS said. Since February - being the month before the coronavirus pandemic gripped the UK - 828,000 fewer people were in payrolled employment.

Safe haven assets, the Japanese yen and gold, were mildly higher on Tuesday. Against the yen, the dollar was quoted at JPY103.78 versus JPY103.81. Gold was quoted at USD1,851.69 an ounce on Tuesday, a touch higher than USD1,848.02 at the London equities close on Monday.

Brent oil was trading at USD56.31 a barrel, rising from USD55.50 late Monday. Oil majors tracked the price of Brent higher, with BP shares up 1.5% at midday, while Royal Dutch Shell 'A' and 'B' shares both rose 1.4%.

Rolls-Royce remained rooted at the bottom of the FTSE 100 but had managed to pare losses by midday. The stock was down 4.5% at 93.62 pence at midday, having traded below the 90p mark earlier in the session.

The jet engine maker said new coronavirus strains and the tighter travel restrictions introduced in their wake is creating short-term uncertainty.

"Continued progress on vaccination programmes is encouraging for the medium-term recovery of air traffic and economic activity. In the near-term, however, more contagious variants of the virus are creating additional uncertainty," Rolls-Royce explained.

Its current forecasts indicate free cash outflow in the region of GBP2 billion in 2021. This is based on widebody engine flying hours for this year at around 55% of 2019 levels, compared to a base case of 70% presented in October.

Russ Mould, investment director at AJ Bell, commented: "The market will be keeping a close eye on the state of the aviation industry and whether the second half of 2021 is realistic for a notable increase in the number of planes flying. That matters for Rolls-Royce as its real money is made from repair and maintenance work rather than the sale of engines, and that requires planes to be in the sky."

JD Sports Fashion fell 1.5% after the sportswear retailer confirmed it is looking into the possibility of an equity raise to fund its expansion.

The FTSE 100-listed sportswear retailer said it is exploring additional funding options with a view to "increasing its flexibility to invest in future strategic opportunities", which could potentially involve a non pre-emptive equity placing. The company didn't put a figure on the potential raise.

On Monday, Sky News reported JD was in talks over an around GBP400 million share sale to fund its expansion.

Among blue-chip stocks in the green at midday was Compass, up 3.3% after Exane raised the contract caterer to Neutral from Underperform.

At the top of the FTSE 250 was Indivior, rallying 11% after saying after the market close on Monday that former parent company Reckitt Benckiser has withdrawn a USD1.4 billion claim against the FTSE 250-listed drugmaker.

In November, Indivior announced that FTSE 100-listed Reckitt Benckiser had submitted a claim against the company. The claim related to an indemnity contained in the demerger agreement entered into between the two companies in November 2014.

Indivior was spun off from the consumer health and hygiene firm and listed on the London Stock Exchange in December of that year.

On Monday, Indivior said RB has agreed to withdraw the USD1.4 billion claim and to release Indivior from any claim for indemnity under the demerger agreement relating to the US Department of Justice and Federal Trade Commission settlements which RB entered into in July 2019, as well as other claims for indemnity. Indivior has agreed to pay RB a total of USD50 million over the next five years.

Reckitt shares were down 1.7% on Tuesday.

Mid-cap UDG Healthcare rose 5.1%. The healthcare services provider said it expects to post a significant rise in earnings for its current financial year as its divisions delivered a first quarter performance ahead of the prior year.

It anticipates that for its financial year ending September 30, constant currency adjusted operating profit will be between 11% to 13% ahead of the USD165.3 million reported in financial 2020. Constant currency adjusted diluted earnings per share is also expected to be between 9% to 11% ahead of the USD47.7 cents recorded the year prior.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 11:44

LONDON MARKET MIDDAY: Stocks boosted as UK recession "already" over

(Alliance News) - Stock prices in London were higher at midday Thursday, with the latest UK purchasing managers' index data indicating that the UK recession is "already" over.

Read more
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more
22 Feb 2024 08:26

Indivior planning to move primary listing to US, shares surge

(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
20 Dec 2023 15:05

London close: Stocks rise as UK inflation slows further

(Sharecast News) - London's stock markets saw a notable upswing on Wednesday, driven by encouraging data revealing a greater-than-anticipated slowdown in UK inflation for November.

Read more
20 Dec 2023 11:56

LONDON MARKET MIDDAY: Stocks sparkle thanks to UK inflation data

(Alliance News) - Stock prices in London were higher at midday Wednesday, as investors felt the festive cheer thanks to cooler-than-expected inflation data for the UK.

Read more
20 Dec 2023 10:59

IN BRIEF: Indivior agrees settlement with Actavis over patent dispute

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Says its subsidiaries Indivior Inc and Indivior UK Ltd has agreed on a settlement deal with Actavis Laboratories UT Inc, a subsidiary of Teva Pharmaceuticals, resolving patent disputes of Actavis's abbreviated new drug application for generic buprenorphine and naloxone sublingual film. Says it has granted Actavis a license to US patent no.11,135,216, allowing it to launch general film products in the US from January 31 2025, unless unexpired patent claims are found to be invalid.

Read more
20 Dec 2023 08:48

LONDON MARKET OPEN: Stocks feeling festive on UK, US rate cut hopes

(Alliance News) - Stock in London enjoyed a broad-based rally at Wednesday's open, as a surprise UK inflation print boosted risk sentiment, with investors pinning their hopes on UK and US interest rate cuts next year.

Read more
20 Dec 2023 07:26

Indivior strikes agreement with Actavis over patent dispute

(Sharecast News) - Indivior announced significant agreement in its ongoing patent dispute with Actavis Laboratories UT, a subsidiary of Teva Pharmaceuticals, on Wednesday.

Read more
5 Dec 2023 15:38

Indivior and Reckitt land legal boost in UK Suboxone claim

(Alliance News) - Indivior PLC and one-time parent Reckitt Benckiser Group PLC were handed a legal victory on Tuesday after the High Court of Justice of England & Wales dismissed a lawsuit related to alleged false marketing of an opioid addiction treatment.

Read more
24 Nov 2023 09:23

LONDON BROKER RATINGS: Investors told to 'sell' Sage and Deliveroo

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
20 Nov 2023 14:59

London close: Stocks mixed ahead of Autumn Statement

(Sharecast News) - London's stock markets saw a mixed performance at the close of trading on Monday, with Ashtead and Compass among the leading losers.

Read more
17 Nov 2023 12:15

Indivior announces $100m share buyback

(Sharecast News) - Pharma group Indivior has announced a $100m share buyback to reduce its issued shared capital and return cash to shareholders.

Read more
17 Nov 2023 12:08

UPDATE: Indivior plans up to USD100 million share buyback programme

(Alliance News) - Indivior PLC on Friday announced a new share buyback programme, as it hailed its outlook for medium-term profitable growth.

Read more
17 Nov 2023 09:46

Indivior to keep Scopia's Jerome Lande on board as agreement extended

(Alliance News) - Indivior PLC on Friday said it changed its existing relationship with Scopia Capital Management LP to keep Scopia representative Jerome Lande on the Indivior board.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.